M. Kraus Co buys $6,203,642 stake in Thermo Fisher Scientific (TMO)

Thermo Fisher Scientific (TMO) : M. Kraus Co scooped up 187 additional shares in Thermo Fisher Scientific during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Jul 6, 2016. The investment management firm now holds a total of 40,629 shares of Thermo Fisher Scientific which is valued at $6,203,642.Thermo Fisher Scientific makes up approximately 3.63% of M. Kraus Co’s portfolio.

Other Hedge Funds, Including , Cullinan Associates Inc reduced its stake in TMO by selling 3,720 shares or 16.73% in the most recent quarter. The Hedge Fund company now holds 18,510 shares of TMO which is valued at $2,762,247. Thermo Fisher Scientific makes up approx 0.22% of Cullinan Associates Inc’s portfolio.

Thermo Fisher Scientific closed down -0.35 points or -0.23% at $152.34 with 9,59,100 shares getting traded on Monday. Post opening the session at $153.07, the shares hit an intraday low of $152.01 and an intraday high of $153.6499 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, Thermo Fisher Scientific reported $1.80 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Apr 28, 2016. Analyst had a consensus of $1.74. The company had revenue of $4294.80 million for the quarter, compared to analysts expectations of $4113.28 million. The company’s revenue was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.63 EPS.

Many Wall Street Analysts have commented on Thermo Fisher Scientific. Company shares were Reiterated by Mizuho on May 27, 2016 to “Buy”, Firm has raised the Price Target to $ 170 from a previous price target of $166 .Company shares were Reiterated by Mizuho on May 19, 2016 to “Buy”, Firm has raised the Price Target to $ 166 from a previous price target of $163 .Company shares were Reiterated by Mizuho on May 3, 2016 to “Buy”, Firm has raised the Price Target to $ 163 from a previous price target of $160 .

Thermo Fisher Scientific Inc. is a provider of analytical instruments equipment reagents and consumables software and services for research manufacturing analysis discovery and diagnostics. The company operates through four segments: Life Sciences Solutions provides reagents instruments and consumables used in biological and medical research discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments provides instruments consumables software and services that are used in the laboratory; Specialty Diagnostics offers diagnostic test kits reagents culture media instruments and associated products and Laboratory Products and Services offers self-manufactured and sourced products for the laboratory.

Leave a Reply

Thermo Fisher Scientific - Is it time to Sell?

Top Brokerage Firms are advising their investors on Thermo Fisher Scientific. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.